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Abstract
Background - End tidal inspiratory ac-
tivity (ETIA) in diaphragm and para-
sternal intercostal muscles can be evoked
in man and in animals by administration
ofhistamine. Exacerbations ofasthma and
administration of histamine are often ac-
companied by hyperinflation. The aims
of the study were to determine (1) the
magnitude of ETIA in response to his-
tamine in man, (2) the relative con-
tributions of chemical and mechanical
stimulation of airway receptors to ETIA,
and (3) the importance of ETIA to hyper-
inflation.
Methods - The effects of inhalation of his-
tamine on the electrical activities of the
diaphragm and parasternal intercostal
muscles measured with surface electrodes
were studied in 21 subjects. The ex-
periments were repeated after inhalation
of 600 pg of salbutamol to prevent his-
tamine induced bronchoconstriction and
concomitant mechanical stimulation of
airway receptors. Subjects were connected
to a closed breathing circuit to measure
the changes in functional residual capacity
(FRC) for the different experiments.
Results - The mean values of histamine
induced ETIA were 60.6% and 46.9% of
peak inspiratory activities during control
conditions for the diaphragm and inter-
costal muscles, respectively. After sal-
butamol histamine induced ETIA was
reduced to about one quarter of pre-sal-
butamol values. FRC increased by 427 ml
as a result of inhalation of histamine, but
after salbutamol this increase was only
53 ml. The data for ETIA and FRC were
interpreted as indicating that the con-
tributions of airflow limitation and ETIA
to histamine induced hyperinflation are
comparable.
Conclusions - Histamine is a forceful stim-
ulus for inducing ETIA. Both chemical
and mechanical stimulation of airway re-
ceptors contribute to evoke ETIA, ofwhich
the contribution of mechanical stimu-
lation is the more important one. ETIA
contributes substantially to histamine in-
duced hyperinflation.
(Thorax 1996;51:1192-1198)
Keywords: end tidal inspiratory activity, histamine,
EMG, lung receptors, P2 agonist, bronchoconstriction.
EMG activity of inspiratory muscles at the end
of expiration has been observed in response to
administration of histamine both in animals'2
and man.34 We have shown in cats that this so
called end tidal inspiratory activity (ETIA) is
a vagal reflex activity which is due to stimulation
of rapidly adapting pulmonary receptors.25
Rapidly adapting pulmonary receptors can be
stimulated by histamine in cats,6 dogs,7 and
rabbits.8 It is not known whether they are stim-
ulated by histamine by direct chemical effects
or by indirect mechanical effects due to
bronchoconstriction, or by a combination of
both.7 12
Exacerbations of asthma and administration
of histamine are often accompanied by hyper-
inflation. 1'-15 Although both bronchocon-
striction and ETIA are accepted as causes of
hyperinflation in bronchial asthma,'6 it has not
yet been shown which is more important. The
aims of the present study were therefore to
determine (1) the magnitude of ETIA in re-
sponse to histamine in man, (2) the relative
contributions of chemical and mechanical
stimulation of airway receptors to ETIA, and
(3) the importance of ETIA to hyperinflation.
To this end, experiments were performed on
human subjects who were challenged with his-
tamine both before and after administration of
the 12 agonist salbutamol. Salbutamol provides
protection against bronchoconstriction caused
by different stimuli such as histamine, 7'8 so
in the latter experiment histamine induced
bronchoconstriction was largely prevented.
Methods
SUBJECTS
Twenty one subjects (nine men) of age range
14-62 years participated in the study. Char-
acteristics of the subjects are presented in table
1. Informed consent was obtained from all
subjects who were naive with respect to
the aims of the study which was approved by
the ethical committee of the hospital.
MEASUREMENT OF RESPIRATORY MUSCLE
FUNCTION
Subjects were connected to a closed breathing
circuit (fig 1) by a mouthpiece and oxygen was
Table 1 Mean (SE) characteristics of the subjects (n= 21)
Mean age (years) 32.5 (2.5)
M:F 9:12
Height (cm) 174.9 (1.5)
Weight (kg) 71.7 (2.6)
FEVy (1) 3.6 (0.19)
FEV, (%pred) 94.7 (3.2)
FEV,/FVC (%) 78.9 (1.9)
FRCpred(l) 3.1 (0.08)
Rrs6(hPa.lI.s) 3.5 (0.36)
FEV,=forced expiratory volume in one second; FVC =forced
expiratory vital capacity; Rrs6 = airway resistance determined at
6 Hz by forced oscillation technique.
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Figure 1 Diagram of the breathing circuit. 1 =subject
connected to the circuit by a mouthpiece; 2 =soda lime;
3 =port for supplying oxygen; 4 =pump for bias flow;
5 = wedge spirometer; 6= oxygen analyser; 7= nebuliser;
8=pump generating flow for aerosol. The equipment dead
space of the circuit was 49 ml.
supplied to maintain the oxygen concentration
in the circuit constant (21%). Gas was sampled
continuously from the circuit for the measure-
ment of the oxygen concentration (Taylor
Servomex) and subsequently fed back into the
system (fig 1). A pump maintained a constant
bias flow in the circuit of at least 120 1/min
which prevented rebreathing of CO2. Exhaled
CO2 was absorbed by soda lime. An aerosol of
saline or histamine could be delivered by a jet
nebuliser (DeVilbiss 646) which was connected
to the circuit near the mouthpiece (fig 1). The
calibrated output of the nebuliser was 0. 13 ml/
min.
The electrical activities of the diaphragm and
intercostal muscles were obtained from two
pairs of electrodes, each pair consisting of two
silver discs of 7 mm diameter which were glued
to the skin, 2 cm apart. The electromyogram
(EMG) ofthe intercostal muscles was obtained
from electrodes placed parasternally in the left
second intercostal space. The EMG of the
diaphragm was obtained from another pair of
electrodes placed between the mid-clavicular
and mid-axillary line in the seventh or eighth
right intercostal space. The rawEMG activities
were amplified, filtered (200-1200 Hz), rec-
tified, and fed into a leaky integrator with a
time constant of 50 ms (Neurolog, Digitimer).
The integrated activities of the diaphragm
and intercostal muscles, the volume signal of
the wedge spirometer, and the oxygen con-
centration of the gas in the breathing circuit
were recorded with a multichannel X-t recorder
(Kipp, The Netherlands). The responses of the
diaphragm, intercostal muscles, and functional
residual capacity (FRC) to inhalation of his-
tamine were studied from these recordings.
EMG activities were also monitored by an
audio monitor.
All subjects were tested in the sitting position.
They were seated in a relaxed posture and were
asked to remain in that position until the end
of the recording. Thus, with good cooperation
from our subjects we were able to minimise
the effect of the postural muscles on recorded
EMG activities. To divert their attention from
breathing they were asked to concentrate on a
poster placed in front of them.
EXPERIMENTAL PROTOCOL
The provocative concentration of histamine
(PC20) at which the forced expiratory volume
in one second (FEVy) fell by 20% of the pre-
challenge value was determined on day 1 with
a histamine challenge test using the method of
Hargreave et al.'9 On day 2 the effects of in-
haling one single concentration of histamine
on EMGs of the diaphragm and intercostal
muscles and on the FRC were studied. This
concentration was the one at which on day 1
FEV, had fallen by 20% or more or, in case of
a non-responsive subject, the highest con-
centration used on day 1 (.8 mg/ml). After
the subject had been connected to the breathing
circuit the recording was started. The recording
included at least five stable control breaths and
continued for the two minutes of histamine
inhalation and a further 1.5 minutes thereafter.
Subsequently, 600 jg of salbutamol (Ventolin)
was administered by a standard metered dose
inhaler. Fifteen minutes later the single dose
histamine test was repeated. In order to eval-
uate the effects of histamine and salbutamol
on airway mechanics, respiratory resistance and
FEV, were determined on four occasions: be-
fore histamine (control), after inhalation of
histamine, 15 minutes after inhalation of sal-
butamol, and after a subsequent inhalation of
histamine.
PULMONARY FUNCTION MEASUREMENTS
Changes in FRC (AFRC) in response to his-
tamine were calculated from the spirogram.
Forced vital capacity (FVC) and FEV, were
obtained by standard spirometric meas-
urements (Fukuda Sangyo). All values were
related to the reference values of the European
Community for Coal and Steel.20
Respiratory resistance was determined by
means ofthe forced oscillation technique which
has been described in detail elsewhere.2' It
has been reported that respiratory resistance
measured at low frequencies correlates well
with airway resistance.22 In the present study
the resistance at 6 Hz was used (Rrs6).
DATA ANALYSIS
Mean values of end tidal EMG activity and of
peak EMG activity were calculated from five
consecutive breaths recorded about 60 seconds
after the inhalation of histamine had been
stopped. These mean values will be referred to
as EMGetHIST and EMGpkHIST respectively. In
a similar way we determined EMGpkCTRL from
the recordings of five consecutive control
breaths of the same experiment taken from
the last part of the control period. ETIA is
represented by EMGet. In order to minimise
the effects of instrumental, intersubject, and
intrasubject scatter in the measured EMG
activity ETIA was expressed as a percentage
of EMGpkCTRL and, for the same reason,
EMGpkHIST was also expressed as a percentage
of EMGpkcTRL.
Changes in FRC were determined from the
difference in FRC between the same groups of
breaths, five control breaths, and five breaths
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Figure 3 Effects of inhalation of histamine on end tidal
inspiratory activity (ETIA) in the diaphragm and
intercostal nmuscles (ICM). ETIA is expressed as a
percentage of mean peak EMG activity of corresponding
control breaths. After inhalation of 600 jg salbutanmol the
histamine induced ETIA had decreased significantly
(p <0.01 and p <0.001 for the diaphragm anid intercostal
muscles, respectively) compared with values before
salbutamol. Data represent nmean values obtained from 21
subjects. Error bars indicate 1 SE. ***p <0. 001 comipared
with control values (Wilcoxon 's test for paired
observations).
Figure 2 Representative recordings of integrated electromyograms of the diaphragm
(EMGDi) and ofparasternal intercostal muscles (EMGIcM) and of the correspondinig
changes in spirometer volume (inspiration up, expiration down) in response to histamine.
A histamine concentration was applied which produced a fall in FEV, of more than 20%.
(A) Breaths during control and after inhalation of histamine. End tidal inspiratory
activity is induced in EMGDI and EMGicv in response to histamine and FRC is
increased. (B) After inhalation of 600 jig salbutamol the experiment was repeated with
the same histamine concentration. End tidal levels of both EMGs are increased only
slightly in response to histamine and in this example FRC did not change at all.
60 seconds after the inhalation of histamine
had been stopped. A mismatch between oxygen
supply and oxygen uptake will cause the base-
line of the spirometer signal to drift one way
or the other which would affect the results
for AFRC. The shift in the baseline of the
spirometer signal is proportional to the de-
viation of the oxygen concentration from 21 %.
The relationship between these two factors was
determined experimentally by adding a known
amount of pure oxygen to the system and by
reading the corresponding change in oxygen
concentration. With the help ofthis relationship
we have corrected the raw data for AFRC
for the aforementioned oxygen concentration
related shift of the spirometer signal. The in-
accuracy of the correction was +6ml. This
error adds to the overall random error in the
determination of AFRC.
All values reported are means (SE). Unless
otherwise indicated, differences were evaluated
Table 2
(n = 21)
Mean (SE) responses of FRC, FEV, and Rrs6 before and after salbutamol
Before salbutanmol After salbutamol
Control Histamline Control Histanmine
AFRC (ml) 427 (67) 53 (16)
FEV,(1) 3.6 (0.19) 2.8 (0.21)*** 3.7 (0.21) 3.5 (0.23)*
Rrs, (hPa.l '.s) 3.5 (0.36) 5.9 (0.48)*** 2.8 (0.22) 3.3 (0.23)**
AFRC = change in functional residual capacity in response to histamine; FEV, = forced expiratory
volume in one second; Rrs6 = airway resistance determined at 6 Hz. *p <0.05; **p <0.01;
***p <0.001 control versus histamine.
for statistical significance using the Wilcoxon's
test for paired observations. A p value of <0.05
was considered to be significant. Statistical ana-
lysis was performed using the statistical soft-
ware package SPSS/PC + (SPSS Inc, Chicago,
Illinois).
Results
EFFECTS OF HISTAMINE ON EMG AND FRC
Figure 2 shows the results for one subject's
recordings of integrated electrical activities of
the diaphragm and intercostal muscles and of
the corresponding changes in lung volume.
The recordings show that, before inhalation of
salbutamol, ETIA is evoked in the diaphragm
and in the intercostal muscles in response to
histamine as end tidal EMGs do not return to
baseline levels (fig 2A). At the same time FRC
is increased. After administration of salbutamol
inhalation ofhistamine evokes hardly any ETIA
and FRC did not change at all in this subject
(fig 2B).
Before inhalation of salbutamol mean (SE)
values of histamine induced ETIA obtained
from 21 subjects were 60.6 (8.5)% and 46.9
(7.0)% of EMGpkCTRL for the diaphragm and
intercostal muscles, respectively (fig 3). The
mean increase in FRC (AFRC) was 427 (67)
ml or 13.7 (2. 1)% ofFRC predicted (table 2, fig
4). In response to histamine, peak inspiratory
EMG activity increased to 375 (46)O% and 364
(49)% of EMGpkCTRL for the diaphragm and
intercostal muscles, respectively (fig 5).
After inhalation of salbutamol histamine in-
ducedETIAwas 16.6 (4.1)o% and 10.9 (2.7)%
for the diaphragm and intercostal muscles, re-
spectively (fig 3). Histamine induced ETIA was
significantly lower after inhalation of sal-
butamol compared with pre-salbutamol values
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Figure 4 Effects of histamine on functional residual
capacity (FRC) before and after inhalation of 600 jig
salbutamol. Changes in FRC are presented as percentage
ofFRC predicted. Data represent means obtained from 21
subjects. Error bars indicate I SE. ***p <0.001 compared
with values before salbutamol (Wilcoxon' test for paired
observations).
(p <0.01 and p <0.001 for the diaphragm and
intercostal muscles, respectively). After sal-
butamol FRC was only slightly though sig-
nificantly (p <0.001) elevated in response to
histamine. The mean increase in FRC was 53
(16) ml or 1.7 (0.5)% of FRC predicted (table
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Figure 5 Effects of inhalation of histamine on peak
inspiratory EMG activity in the diaphragm and
intercostal muscles (ICM). Peak EMG activity is
expressed as a percentage of mean peak inspiratory EMG
activity of corresponding control breaths. After inhalation
of 600 jig salbutamol the effects of histamine on peak
inspiratory EMG activities are abolished. Data represent
means obtained from 21 subjects. Error bars indicate 1
SE. *** p<0. 001 compared with control values
(Wilcoxon test for paired observations).
Table 3 Meani (SE) responses of ETIA, FRC, and FEV, to histaninle in a grouip of
subjects with no significant decrease in FEV, in response to histamine after salbuitamol
inhalation (n = 9)
Before salbuitanol After salbutamol
ETIADI(o) 77.6 (14.4)** 31.9 (6.5)
ETIAicM(0Yo) 49.9 (11.9)* 17.7 (4.9)
AFRC (% FRCpred) 15.6 (3.7)** 2.0 (0.9)
FEV, (% control) 80.5 (4.2)** 100.1 (0.6)
ETIADi, ETIAicM= end tidal inspiratory activity in the diaphragm and intercostal muscles;
FRC= functional residual capacity; FEV, =forced expiratory volume in one second.
*p <0.05; **p <0.01 before versus after salbutamol (Wilcoxon's test). ETIA in the diaphragm
was significantly (p <0.05) higher than in the intercostal muscles for both conditions.
T
Control
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Figure 6 Responses offorced expiratory volunme in one
second (FEVI; 0) and respiratory resistance at 6 Hz
(Rrs,; A) as percentage predicted in response to histamine
before and after inhalationi of 600 jig salbutamol. Before
inhalation of salbutamol Rrs, increased and FEV,
decreased significantly in response to histamine conipared
with control. After inhalation of salbutamol these responses
to histamine were much diminished. Data represent miieanis
obtained from 21 subjects. Error bars indicate I SE.
***p<0. 001; **p<0. 01 (VilcoxonO' test for paired
observationis). Note inverse scale for FEV,.
2, fig 4). After salbutamol peak inspiratory
EMG activity did not change significantly in
response to histamine being 109 (10)% and 1 10
(1 1)% ofEMGpkCTRL of the same recording for
the diaphragm and intercostal muscles, re-
spectively (fig 5).
EFFECTS OF HISTAMINE AND SALBUTAMOL ON
RESPIRATORY RESISTANCE AND FEV,
Changes in airway diameter will influence res-
piratory resistance at 6 Hz (Rrs6) and FEVI.
Effects of histamine on Rrs, and FEV, obtained
from 21 subjects before and after inhalation of
salbutamol are shown in table 2 and fig 6. Rrs6
increased significantly (p <0.001) in response
to histamine compared with control. After sal-
butamol only a small increase in Rrs6 was found
in response to histamine compared with control
values after salbutamol (fig 6). FEV, decreased
significantly compared with control values
(p <0.001) in response to histamine (table
2, fig 6). After salbutamol a small but still
significant (p <0.01) fraction of that response
remained (table 2, fig 6).
For further interpretation of the results a
subgroup was defined including only those sub-
jects whose FEV, decreased by less than 2%
in response to histamine after salbutamol. The
mean values of ETIA, AFRC, and FEV, for
this subgroup are presented in table 3.
Discussion
Inhalation of histamine evoked ETIA in the
diaphragm and intercostal muscles in all of our
subjects. After administration of salbutamol the
magnitude of histamine induced ETIA was
considerably diminished. Similarly, FRC in-
creased significantly in response to histamine,
while this increase was minimal after sal-
60
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butamol. FEVy decreased and Rrs6 increased
in response to histamine. After salbutamol,
inhalation of histamine only slightly affected
these indices of bronchoconstriction.
EMG AND SURFACE ELECTRODES
It has been reported that the electrical activity
ofthe diaphragm detected by surface electrodes
is comparable with that detected by oeso-
phageal electrodes23"25 and it is concluded
that there is only a minimal contamination
from the activity of other chest muscles. In
man electrical expiratory activity was found in
the transversus abdominis muscle but not in
the external oblique or the rectus abdominis
muscles during expiration.26 It is not likely,
therefore, that the EMG of the diaphragm
detected by surface electrodes is contaminated
by electrical activity of abdominal muscles dur-
ing expiration. Furthermore, the relationship
between surface and oesophageal EMGs has
not been found to be modified by changes in
lung volume.2527 Contamination of inspiratory
EMGs by expiratory activity is unlikely since
our results for the EMGs of the diaphragm
and intercostal muscles (figs 3 and 5) were
comparable and were qualitatively the same as
those found in our experiments in animals2 in
which we used intramuscular electrodes. The
use of surface electrodes to record EMGs of
the diaphragm and intercostal muscles during
the experimental conditions used in this study
therefore appears valid.
INDICES OF BRONCHOCONSTRICTION
Several pulmonary function variables can
quantify the patency of the airways. FEV1 de-
creases with increasing bronchoconstriction. It
has been shown that Rrs6 is increased in patients
with chronic obstructive pulmonary disease
(COPD) and with asthma.22 The changes in
FEV1 and Rrs6 in response to histamine and
after salbutamol were as expected (table 2,
fig 6). After salbutamol these indices reached
values which were not different from pre-sal-
butamol control values or even "better". FEV,
decreased significantly in response to histamine
even after inhalation of salbutamol (table 2,
fig 6). Thus, histamine induced broncho-
constriction was not fully prevented by sal-
butamol although mean values of FEV, after
histamine (94.8% predicted) were comparable
with pre-salbutamol control values (94.7% pre-
dicted). Furthermore, changes in FEV1 and
Rrs6 were very similar with respect to ad-
ministration of histamine and salbutamol (fig
6).
PEAK INSPIRATORY EMG ACTIVITY
Peak EMG activity was increased significantly
in response to histamine (about 3.5 times con-
trol values). This may have been due to a
delayed off switch of inspiration because of
increased airway resistance as well as to en-
hanced stimulation of inspiratory activity by
airway receptors. This is supported by the ob-
servation that the increased peak EMG activity
was no longer observed after broncho-
constriction had been prevented by salbutamol.
Furthermore, mean minute ventilation after
administration of histamine (8.7 (0.5) 1/min)
was not significantly different from control val-
ues (8.1 (0.5) 1/min). Hence, changes in peak
EMG activity cannot be attributed to changes
in arterial carbon dioxide tension.
END TIDAL INSPIRATORY ACTIVITY
It has been shown that histamine can induce
ETIA in rabbits,' cats,2 and man.4"4 In a pre-
vious study in cats we have shown that stimu-
lation of rapidly adapting pulmonary receptors
elicits ETIA, whereas ETIA is inhibited by
stimulation of slowly adapting receptors.25 His-
tamine induced bronchoconstriction is caused
both by stimulation ofH1 receptors in bronchial
smooth muscles and by stimulation of rapidly
adapting pulmonary receptors via a vagal
reflex.2829 In animals the activity of rapidly
adapting pulmonary receptors has been found
to be increased in response to inhalation of
irritant gases30 and by intravenous or intra-
tracheal application of histamine.89 It has
been shown in dogs that when histamine is
administered at intervals of longer than 15
minutes the responses of rapidly adapting pul-
monary receptors are reproducible.3' In the
further discussion we start from the assumption
that the underlying mechanisms of ETIA in
man are similar to those found in experimental
animals summarised above.
The present study shows that inhalation of
histamine is a powerful stimulus for inducing
ETIA, both in the diaphragm and in intercostal
muscles in man. After inhalation of salbutamol
histamine induced ETIA was considerably re-
duced, indicating that bronchoconstriction was
involved in causing ETIA and, by extrapolation
of the abovementioned findings obtained in
experimental animals, this would mean that
the enhanced ETIA after administration of
histamine is mainly due to mechanical stimu-
lation of rapidly adapting pulmonary receptors
by bronchoconstriction. This will be discussed
in more detail below. Slowly adapting receptors
are stimulated by increased lung volume, so if
stimulation of slowly adapting receptors also
inhibits ETIA in man, histamine induced
hyperinflation may diminish the magnitude of
histamine induced ETIA through rapidly ad-
apting receptors.
After administration of salbutamol +
histamine, FEV1 and Rrs6 reached levels which
did not differ from their control values before
salbutamol (p=0.71 and 0.69, respectively).
This suggests that the remaining ETIA after
salbutamol+histamine is due to direct chem-
ical stimulation of rapidly adapting receptors.
After salbutamol, however, a small but sig-
nificant decrease in FEV1 and increase in Rrs6
(compared with controlsa,6) were still observed
in response to histamine (fig 6). Thus, it cannot
be ruled out that after salbutamol some mech-
anical stimulation of rapidly adapting receptors
by histamine induced bronchoconstriction was
still present. In the results a subgroup of nine
subjects was defined. The FEV1 in these sub-
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jects decreased in response to histamine before
salbutamol. After salbutamol, however, there
was no significant decrease in FEVy in response
to histamine compared with controlsalb (table
3). Values ofETIA after salbutamol + histamine
should therefore be attributed to chemical
stimulation of rapidly adapting receptors in
these subjects. The mean values of histamine
induced ETIA in these nine subjects were 41%
and 36% of their pre-salbutamol values for
the diaphragm and intercostal muscles, re-
spectively. Thus, chemical stimulation of
rapidly adapting receptors contributed for
somewhat more than one third of the mag-
nitude of ETIA. Hence, we may conclude that
mechanical stimulation of rapidly adapting re-
ceptors by contraction of bronchial smooth
muscles was the more important stimulus in
histamine induced ETIA before salbutamol in
this subgroup. That ETIA can be induced
by mechanical stimulation of rapidly adapting
receptors is in accordance with our previous
findings that continuous negative airway pres-
sure (CNAP) - which is a strong mechanical
stimulus for rapidly adapting receptors - in-
duces ETIA in cats5 and in man.32
The contribution of chemical stimulation
to the total stimulation of rapidly adapting
receptors may depend on the concentration
of histamine used. In subjects with bronchial
hyperresponsiveness a low dose of histamine
causes a firm bronchoconstriction with cor-
responding mechanical stimulation of rapidly
adapting receptors but, because of the low
histamine concentration, chemical stimulation
of the receptors may be small. The PC20 of
eight of our nine subjects in the subgroup
discussed above was . 8 mg/ml histamine, thus
the concentration of histamine administered
to these subjects was rather high (mean 12.5
(1.9) mg/ml). In the remaining 12 subjects the
concentration was lower (mean 9.68 (2.03) mg/
ml). It is likely, therefore, that the conclusion
derived from the subgroup of the nine non-
responsive subjects will also apply to the re-
sponsive subjects - namely, that mechanical
stimulation of rapidly adapting receptors is the
more important stimulus in histamine induced
ETIA.
The properties of rapidly adapting receptors
suggest a positive feedback mechanism as
stimulation of the receptors induces reflex
bronchoconstriction which in turn stimulates
the receptors. However, the concomitant in-
creases in ETIA and flow limitation result in
an increase in FRC which is beneficial by in-
creasing the diameter of the airway.
ETIA AND HYPERINFLATION
In asymptomatic asthmatic subjects the end
expiratory pleural pressure has been shown to
be more negative during histamine induced
hyperinflation than can be accounted for by
the chest wall relaxation pressure, indicating
the presence of ETIA.'4 Therefore, in addition
to airflow limitation ETIA may be one of the
causes of hyperinflation. As mentioned before,
after administration of salbutamol + histamine
the FEVy and Rrs6 reached levels which were
comparable to their pre-salbutamol control val-
ues. It is likely, therefore, that the small his-
tamine induced increase in FRC after
salbutamol (table 2, fig 4) is solely due to ETIA
which is also small in that condition (fig 3).
Siafakas et a133 showed that there is a close
proportional relationship between phrenic ac-
tivity and the driving pressure of the respiratory
system during inspiration. In static respiratory
conditions this pressure is linearly related to
lung volume in the middle of the range.34 In
quiet breathing, as occurred in our ex-
periments, static conditions are approximated
at the turning points of inspiration and ex-
piration. The findings of Siafakas et al suggest
that, in control conditions with quiet breathing
restricted to the mid-range of lung volumes,
tidal volume (VT) is proportional to peakEMG
activity and, further, that ETIA alone may
account for an increase in FRC equal to ETIA
times VTCTRL (AFRC =ETIA . VTCTRP). Note
that ETIA is expressed as a percentage of
EMGpkCTRL. Computation of this product for
the total group of 21 subjects using the mean
values of ETIA for the diaphragm and inter-
costal muscles resulted in the following es-
timated values for AFRC for ETIA alone: 328
(55) ml for the experiments before salbutamol
and 90 (24) ml for the experiments after sal-
butamol. A comparison ofthese data with those
measured for AFRC (table 2) suggests that the
contribution of ETIA to histamine induced
hyperinflation in our experiments is larger than
that of flow limitation before salbutamol and
that ETIA is the sole determinant of hyper-
inflation after salbutamol, which is consistent
with the absence of flow limitation in that
condition.
This study was supported by the Netherlands Asthma Founda-
tion (NAF-88.26).
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